Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
2.
eNeurologicalSci ; 20: 100249, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32613094

ABSTRACT

•Acute management of SLEs differs from usual therapy in classic stroke patients.•IV L-Arginine should be administered urgently in the setting of a SLE.•If mental status is altered, an EEG should be performed to rule out a non-convulsive status.

3.
J Neuroimmunol ; 339: 577111, 2020 02 15.
Article in English | MEDLINE | ID: mdl-31756639

ABSTRACT

Narcolepsy-type 1 is a neurological sleep-disorder caused by a selective loss of hypothalamic orexin/hypocretin-producing neurons whose underlying mechanism is considered to be immune-mediated. We report the case of a 16 year-old girl with excessive daytime sleepiness, hypnagogic/hypnopompic hallucinations and cataplexy, fulfilling narcolepsy-type 1 diagnostic criteria. She was HLA-DQB1*06:02/DQA1*01:02 positive. CSF analysis demonstrated positive IgG oligoclonal bands, pleocytosis and hypocretin-1 below detection limit. Other autoimmune processes were excluded, including autoimmune encephalitis. After treatment with intravenous immunoglobulins sleep-related hallucinations transiently improved for a month. This case's CSF inflammatory findings support the role of neuroinflammation in narcolepsy-type 1 development in genetically predisposed patients.


Subject(s)
Leukocytosis/cerebrospinal fluid , Leukocytosis/diagnosis , Narcolepsy/cerebrospinal fluid , Narcolepsy/diagnosis , Oligoclonal Bands/cerebrospinal fluid , Adolescent , Biomarkers/cerebrospinal fluid , Female , Humans , Immunoglobulins, Intravenous/therapeutic use , Leukocytosis/drug therapy , Narcolepsy/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL